Grantham, Mayo, Van Otterloo & Co (GMO)’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,973,742
Closed -$55.1M 752
2022
Q2
$55.1M Buy
1,973,742
+331,322
+20% +$9.84M 0.3% 64
2022
Q1
$51.5M Buy
+1,642,420
New +$51.7M 0.25% 72

Other funds holding HR

Grantham, Mayo, Van Otterloo & Co (GMO)'s HR Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Healthcare Realty (HR) in Q3 2022, closing a stake of 1,973,742 shares — an estimated $55.1M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HR in Q1 2022 and held it in 2 quarters. The position peaked at $55.1M in Q2 2022. 393 funds tracked by Wall St. Rank hold HR as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Healthcare Realty position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 1,973,742 Healthcare Realty shares in Q3 2022, an estimated $55.1M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Healthcare Realty in Q1 2022 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Healthcare Realty position peaked at $55.1M in Q2 2022.
  • 393 funds tracked by Wall St. Rank held Healthcare Realty as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.